(Q42617070)

3 November 2017

title

Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg (English)

1 reference

3 November 2017

1 reference

Leigh A Stephens

1

1 reference

3 November 2017

Katy H Malpass

series ordinal

2

1 reference

3 November 2017

Stephen M Anderton

series ordinal

3

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

European Journal of Immunology

3 November 2017

published in

1 reference

3 November 2017

volume

39

1 reference

3 November 2017

issue

4

1 reference

3 November 2017

page(s)

1108-1117

1 reference

Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

Selection and fine-tuning of the autoimmune T-cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Foxp3-dependent programme of regulatory T-cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Multi-faceted control of autoaggression: Foxp3+ regulatory T cells in murine models of organ-specific autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

A function for interleukin 2 in Foxp3-expressing regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

The role of regulatory T cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Regulatory T-cell physiology and application to treat autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

What does the future hold for cell-based tolerogenic therapy?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Low avidity recognition of self-antigen by T cells permits escape from central tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839073

7 January 2021

Identifiers

DOI

10.1002/EJI.200839073

1 reference

3 November 2017

1 reference